NO970581L - Fremgangsmåte for fremstilling av 4-oksoimidazoliniumsalter - Google Patents

Fremgangsmåte for fremstilling av 4-oksoimidazoliniumsalter

Info

Publication number
NO970581L
NO970581L NO970581A NO970581A NO970581L NO 970581 L NO970581 L NO 970581L NO 970581 A NO970581 A NO 970581A NO 970581 A NO970581 A NO 970581A NO 970581 L NO970581 L NO 970581L
Authority
NO
Norway
Prior art keywords
rog
preparation
strong acid
oxoimidazolinium
salts
Prior art date
Application number
NO970581A
Other languages
English (en)
Other versions
NO970581D0 (no
NO306674B1 (no
Inventor
Barry Jackson
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of NO970581D0 publication Critical patent/NO970581D0/no
Publication of NO970581L publication Critical patent/NO970581L/no
Publication of NO306674B1 publication Critical patent/NO306674B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/29—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups and acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/44—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

4-Oksoimidazoliniumsalte: med den generelle forme!. hvori Rog Renten uavhengig av hverandre betyr C_-aikyl, C-io-alkenyl, C.i_7-cyk!oalk>'l eller eventuelt substituiert aryl, arylalkyl, heteroary! eller heteroarylalkyl, eller Rog Rsammen med karbonatomet som forbinder dem danner en tre- til syv-leddet mettet eller umettet karbocyklisk eller heterocyklisk ring, Ren C-alkylgruppe, C--alkenylgruppe, C--cykloalkylgruppe, arylgruppe, arylalkylgruppe eller heteroarylgruppe og A" er et anion av en sterk syre, fremstilles ved cyklisering av et a-acylamino-nitril i et ikke-vandig løsningsmiddel i nærvær en lavere alkohol og en sterk syre. Forbindelseene er mellomprodukter for farmasøytiske virkestoffer som for eksempel Angiotensin II-antagonister.
NO970581A 1996-02-09 1997-02-07 FremgangsmÕte for fremstilling av 4-oksoimidazoliniumsalter NO306674B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH33296 1996-02-09

Publications (3)

Publication Number Publication Date
NO970581D0 NO970581D0 (no) 1997-02-07
NO970581L true NO970581L (no) 1997-08-11
NO306674B1 NO306674B1 (no) 1999-12-06

Family

ID=4184613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970581A NO306674B1 (no) 1996-02-09 1997-02-07 FremgangsmÕte for fremstilling av 4-oksoimidazoliniumsalter

Country Status (18)

Country Link
US (1) US5698704A (no)
EP (1) EP0789019B1 (no)
JP (1) JP4224629B2 (no)
KR (1) KR100490220B1 (no)
CN (1) CN1071747C (no)
AT (1) ATE202090T1 (no)
CA (1) CA2196263C (no)
CZ (1) CZ291500B6 (no)
DE (1) DE59703745D1 (no)
DK (1) DK0789019T3 (no)
ES (1) ES2158385T3 (no)
GR (1) GR3036558T3 (no)
HU (1) HU225694B1 (no)
NO (1) NO306674B1 (no)
PL (1) PL191419B1 (no)
PT (1) PT789019E (no)
SK (1) SK282845B6 (no)
TW (1) TW407152B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU218681B (hu) * 1997-07-25 2000-10-30 Sanofi-Synthelabo Eljárás 1,3-diaza-spiro(4,4)non-1-én-4-on-származékok előállitására és 1-ciano-1-(acil-amino)-ciklopentán intermedierek
HU218680B (hu) * 1997-07-25 2000-10-30 Sanofi-Synthelabo Eljárás 1,3-diaza-spiro[4,4]non-1-én-4-on-származékok előállítására és 1-ciano-1-(acil-amino)-ciklopentán intermedierek
US6096745A (en) * 1998-03-25 2000-08-01 Bristol-Myers Squibb Co. Imidazolone anorectic agents: III. heteroaryl derivatives
EP0945441A3 (de) * 1998-03-27 2002-07-17 Degussa AG Verfahren zur Herstellung von cyclischen 4-Oxoamidinen
US5910595A (en) * 1998-06-26 1999-06-08 Salsbury Chemicals, Inc. Process for preparing oximidazoles
EP1537074B1 (en) * 2002-09-04 2019-02-27 Merck Canada Inc. Cathepsin cysteine protease inhibitors
US8796305B2 (en) 2012-11-05 2014-08-05 Bayer Pharma Aktiengesellschaft Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US8778964B2 (en) 2012-11-05 2014-07-15 Bayer Pharma Aktiengesellschaft Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
US9126998B2 (en) 2012-11-05 2015-09-08 Bayer Pharma AG Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US9624214B2 (en) 2012-11-05 2017-04-18 Bayer Pharma Aktiengesellschaft Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US9776997B2 (en) 2013-06-04 2017-10-03 Bayer Pharma Aktiengesellschaft 3-aryl-substituted imidazo[1,2-A]pyridines and their use
CA2920565A1 (en) 2013-08-08 2015-02-12 Bayer Pharma Aktiengesellschaft Substituted pyrazolo[1,5-a]pyridine-3-carboxamides and use thereof
US9688699B2 (en) 2014-02-19 2017-06-27 Bayer Pharma Aktiengesellschaft 3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
CN106715426A (zh) 2014-03-21 2017-05-24 拜耳医药股份有限公司 氰基取代的咪唑并[1,2‑a]吡啶甲酰胺及其用途
CA2969265A1 (en) 2014-12-02 2016-06-09 Bayer Pharma Aktiengesellschaft Substituted pyrazolo[1,5-a]pyridines and imidazo[1,2-a]pyrazines and their use
EP3227287B1 (de) 2014-12-02 2019-08-07 Bayer Pharma Aktiengesellschaft Heteroaryl-substituierte imidazo[1,2-a]pyridine und ihre verwendung
EP3286185A1 (de) 2015-02-05 2018-02-28 Bayer Pharma Aktiengesellschaft Substituierte pyrazolo[1,5-a]pyridin-3-carboxamide und ihre verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4709036A (en) * 1985-06-13 1987-11-24 American Cyanamid Company Process for the preparation of herbicidal 2-(4,4-disubstituted-5-oxo-2-imidazolin-2-yl)benzoic, nicotinic and quinoline-3-carboxylic acids, esters and salts
TW201738B (no) * 1990-03-20 1993-03-11 Sanofi Co
WO1993004045A1 (en) * 1991-08-19 1993-03-04 E.I. Du Pont De Nemours And Company Angiotensin ii receptor blocking imidazolinone derivatives

Also Published As

Publication number Publication date
KR100490220B1 (ko) 2005-09-08
PT789019E (pt) 2001-11-30
CA2196263A1 (en) 1997-08-10
HU225694B1 (en) 2007-06-28
HUP9700380A3 (en) 1998-04-28
JPH09227527A (ja) 1997-09-02
EP0789019B1 (de) 2001-06-13
EP0789019A1 (de) 1997-08-13
CZ38697A3 (en) 1997-08-13
CN1162595A (zh) 1997-10-22
JP4224629B2 (ja) 2009-02-18
GR3036558T3 (en) 2001-12-31
HUP9700380A2 (en) 1997-10-28
CA2196263C (en) 2004-10-26
CN1071747C (zh) 2001-09-26
PL191419B1 (pl) 2006-05-31
HU9700380D0 (en) 1997-03-28
ATE202090T1 (de) 2001-06-15
TW407152B (en) 2000-10-01
SK282845B6 (sk) 2002-12-03
DK0789019T3 (da) 2001-09-03
PL318370A1 (en) 1997-08-18
ES2158385T3 (es) 2001-09-01
KR970061874A (ko) 1997-09-12
CZ291500B6 (cs) 2003-03-12
DE59703745D1 (de) 2001-07-19
NO970581D0 (no) 1997-02-07
NO306674B1 (no) 1999-12-06
SK16097A3 (en) 1997-09-10
US5698704A (en) 1997-12-16

Similar Documents

Publication Publication Date Title
NO970581L (no) Fremgangsmåte for fremstilling av 4-oksoimidazoliniumsalter
HK14789A (en) Indoles
NO964813D0 (no) Fremgangsmåte for stabilisering av duocarmycinderivater
ATE51621T1 (de) Bicyclische kondensierte n-(4-piperidinyl)-2imidazolamin-derivate.
NO810684L (no) Fremgangsmaate ved fremstilling av indanderivater.
DE60026404D1 (de) Verfahren zur Herstellung von Benzothiophen-Derivaten
NO159592C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinderivater.
ATE96772T1 (de) Substituierte 2-alkinylphenole mit entzuendungshemmender wirkung, verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
RU95105435A (ru) N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства
AU2002323570A1 (en) Bicyclic compounds as inhibitors of chemokine binding to us28
KR890003730A (ko) 1-페닐-3-(1-피페라지닐)-1h-인다졸, 그의 제조방법 및 중간생성물, 및 약제로서의 용도
DE69330601D1 (de) Serotoninergische ergolin derivate
NO20024198D0 (no) Fremgangsmåte ved fremstilling av citalopram
NO180269C (no) Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater
KR900018082A (ko) 페닐알카노산의 에스테르
NO20010121D0 (no) Fremgangsmåte for fremstilling av (1R,4S)-2- azabicyklo[2.2.1]hept-5-en-3-on-derivater
KR910004632A (ko) 신규한 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법
ES8106517A1 (es) Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos.
CA2272665A1 (en) Method of treating glaucoma and ischemic retinopathy
KR920006355A (ko) 2-(4-피페리디닐)-1-H-피리도[4,3-b]인돌-1-온 및 관련화합물, 이의 제조를 위한 중간체 및 이의 제조방법
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
NZ335919A (en) (4r,5s,6s,7r)-hexahydro-1-[5-(3-aminoinazole)methyl]-3-butyl-5 ,6-dihydroxy-4,7-bis[phaenylmethyl]-2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor
PT84635A (en) Process for the preparation of stable injectable compositions containing 4-amino-5-chloro-n-]2-(diethylamino) ethyl"-2-](substituted) alkoxy" benzamide antiemetic agents
TH9839A (th) อนุพันธ์โดโลเบนโซควิโนลีน,การเตรียมสารเหล่านั้นและการใช้สารเหล่าเป็นยาต่อต้านอาการหัวใจเต้นไม่ปกติ
IE832769L (en) Acridanone derivative.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees